The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of tislelizumab combined with lenvatinib and FOLFOX4-HAIC in conversion therapy of middle-advanced stage hepatocellular carcinoma (HCC): A real-world retrospective study.
 
Kai Tan
No Relationships to Disclose
 
Xiaojun He
No Relationships to Disclose
 
Hu Zhang
No Relationships to Disclose
 
Shoujie Zhao
No Relationships to Disclose
 
Chenyu Gong
No Relationships to Disclose
 
Yaoyao Zhao
No Relationships to Disclose
 
Haiyan Nan
No Relationships to Disclose
 
Li Zang
No Relationships to Disclose
 
Zhonghua Luo
No Relationships to Disclose
 
Jikai Yin
No Relationships to Disclose
 
Xilin Du
No Relationships to Disclose